Alex Mitchell, Vice President, Operations, Sentry BioPharma Services, discusses the growing use of FTZs by pharmaceutical ...

The CNPV pilot program reduces review times from 10-12 months to 1-2 months, benefiting generics and biosimilars. Companies must align market access, manufacturing, and post-approval readiness with ...

The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...

The company's two new products—the EOS-920 and the EOS-620 Seal—are designed to meet the evolving needs of a wide range of ...

CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), ...

FIIs and DIIs together invested heavily in these two stocks – one is from the banking sector, another from pharma, a rare ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks ...

Thermo Fisher Scientific Inc opens a state-of-the-art packaging and distribution facility in Ahmedabad to better serve pharmaceutical customer growth in India and their increasing need for clinical ...

The Madison Small Cap Fund (Class Y) was down 1.3% in the period, significantly underperforming the benchmarks.

Move enables it to meet increasing demand for logistics services amid development of the Johor-Singapore Special Economic ...

Detailed price information for Wellgistics Health Inc (WGRX-Q) from The Globe and Mail including charting and trades.

Evolving patient needs are driving new drug development paradigms. For complex genetic diseases, traditional therapies often fall short. Gene therapies and nucleic acid medicines offer a way to repair ...